BNO 5.26% 20.0¢ bionomics limited

Looks to be breaking down, page-12

  1. 707 Posts.
    lightbulb Created with Sketch. 78
    Thanks Windshift.

    I was pleased to see that enrollment in PTSD trial will complete this quarter.

    Thus the read-out should be early July unless enrollments finish sooner than 31st March.

    There was also some indication that there has been good interest in the oncology assets.

    Whether this translates into a serious cash offer remains to be seen.

    I read somewhere that the oncology assets need to be dealt with by 30th June.

    My thinking is that CEO has been given a deadline and presumably bonus payment hanging on that outcome.

    As ever, we wait.................
 
watchlist Created with Sketch. Add BNO (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.